INFU vs DXCM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

INFU

60.0
AI Score
VS
INFU Wins

DXCM

49.3
AI Score

Investment Advisor Scores

INFU

60score
Recommendation
BUY

DXCM

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric INFU DXCM Winner
Forward P/E 22.7273 29.3255 INFU
PEG Ratio 1.732 1.401 DXCM
Revenue Growth -3.0% 15.0% DXCM
Earnings Growth 123.9% 92.2% INFU
Tradestie Score 60.0/100 49.3/100 INFU
Profit Margin 5.5% 19.3% DXCM
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD INFU

Relative Price Performance (Last 90 Days)

INFU 1M: -8.8% · 3M: -9.8% DXCM 1M: +21.2% · 3M: +40.1%

Current Technical Phase

INFU

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -1.0%) with fading momentum, RSI 47

RSI (14): 46.8 · Price: $9.14

DXCM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 69

RSI (14): 68.5 · Price: $83.45

Fundamentals Snapshot

Metric INFU DXCM
Market Cap
Forward P/E 16.8 27.1
Trailing P/E 24.8 32.3
Revenue (TTM)
Revenue Growth 0.0% 0.2%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.2%
EPS 0.37 2.31
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, INFU is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.